Discovery Without Boundaries

Total Page:16

File Type:pdf, Size:1020Kb

Discovery Without Boundaries DISCOVERY WITHOUT BOUNDARIES Strategic Plan Summary 2013 The Francis Crick Institute is an exciting project to create a world-leading multi-disciplinary biomedical research institute at the heart of OUR London. The institute has been named in honour of British scientist Francis Crick, who was jointly VISION awarded the Nobel Prize in Physiology or Medicine for his discovery of the structure of DNA in 1953. The project is supported by six of the world’s most influential and To discover the biology We are: respected scientific organisations: Cancer Research UK; the Medical underlying human health, Research Council (MRC); the Wellcome Trust; UCL (University College Bold London); Imperial College London and King’s College London. improving the treatment, We support ground-breaking discovery diagnosis and prevention The Crick will bring together two existing world-class research institutes science, pursue excellence on the − Cancer Research UK’s London Research Institute (LRI) and the MRC of human disease and international stage, and are not National Institute of Medical Research (NIMR) − enabling scientists from generating economic afraid to do things differently. these two organisations to work under one roof alongside colleagues from the three university founders and new recruits funded by the Wellcome opportunities for the UK. Imaginative Trust and others. By pooling this collective knowledge and expertise, We take a long-term view, encourage The Francis Crick Institute will be a new we expect to achieve quicker and more profound advances in our creative approaches, and explore and distinctive medical research institute. understanding of health and disease. connections between disciplines. Opening in 2015, the institute will be located in London, but our vision is UK-wide, and relevant world-wide. Open Our work will help to understand We are permeable to outside talent why disease develops and to find new and ideas and committed to transparent ways to diagnose, prevent and treat science for the public good that meets a range of illnesses − such as cancer, the highest ethical, animal welfare heart disease and stroke, infections and and biosecurity standards. neurodegenerative diseases. We will bring together outstanding scientists from all Dynamic disciplines, carrying out research that will help improve the health and quality We continually develop and refresh of people’s lives, and keeping the UK our science, are open to pursuing new at the forefront of medical innovation. opportunities, and adaptable enough to change course quickly. Collegial We mentor and support our staff, forge scientific connections in the UK and internationally and work with our founders and the public to support the development of the UK science and innovation ecosystem. View from St Pancras International. © Justin Piperger Photography/Wadsworth3 © Justin Piperger Photography/Wadsworth3 Piperger Justin © View from St Pancras International. International. Pancras St from View s College London College s g’ Kin • London College Imperial • London) College (University UCL Cancer Research UK • Medical Research Council • The Wellcome Trust Trust Wellcome The • Council Research Medical • UK Research Cancer and innovation ecosystem. innovation and the development of the UK science science UK the of development the WWW.CRICK.AC.UK founders and the public to support support to public the and founders internationally and work with our our with work and internationally scientifi c connections in the UK and and UK the in connections c scientifi SUMMARY 2013 SUMMARY We mentor and support our staff, forge forge staff, our support and mentor We Collegial © The Francis Crick Institute Crick Francis The © STRATEGIC PLAN PLAN STRATEGIC Discussion at lab meeting. meeting. lab at Discussion Back cover: cover: Back and Holger Gerhardt, LRI Gerhardt, Holger and BOUNDARIES to change course quickly. course change to highlighting blood vessels. © Claudio Franco Franco Claudio © vessels. blood highlighting at the forefront of medical innovation. medical of forefront the at Laser scanning confocal microscopy image image microscopy confocal scanning Laser opportunities, and adaptable enough enough adaptable and opportunities, publications of people’s lives, and keeping the UK UK the keeping and lives, people’s of © The Francis Crick Institute Crick Francis The © WITHOUT www.crick.ac.uk/ our science, are open to pursuing new new pursuing to open are science, our during National Science and Engineering Week. Week. Engineering and Science National during will help improve the health and quality quality and health the improve help will of the strategy please visit visit please strategy the of We continually develop and refresh refresh and develop continually We Local school children making lava lamps lamps lava making children school Local To download a full version version full a download To disciplines, carrying out research that that research out carrying disciplines, DISCOVERY DISCOVERY © The Francis Crick Institute Crick Francis The © Dynamic together outstanding scientists from all all from scientists outstanding together in the Immunobiology Laboratory, LRI. Laboratory, Immunobiology the in Discussing phenotyping strategies strategies phenotyping Discussing Front cover: cover: Front neurodegenerative diseases. We will bring bring will We diseases. neurodegenerative and biosecurity standards. biosecurity and IMAGE CREDITS IMAGE heart disease and stroke, infections and and infections stroke, and disease heart the highest ethical, animal welfare welfare animal ethical, highest the range of illnesses − such as cancer, cancer, as such − illnesses of range 44 (0)800 028 6731 028 (0)800 44 + Tel: science for the public good that meets meets that good public the for science ways to treat, diagnose and prevent a a prevent and diagnose treat, to ways [email protected] Email: and ideas and committed to transparent transparent to committed and ideas and why disease develops and to fi nd new new nd fi to and develops disease why 215 Euston Road, London, NW1 2BE NW1 London, Road, Euston 215 We are permeable to outside talent talent outside to permeable are We Our work will help to understand understand to help will work Our The Francis Crick Institute, Institute, Crick Francis The UK-wide, and relevant world-wide. world-wide. relevant and UK-wide, Open located in London, but our vision is is vision our but London, in located based at the following address: following the at based Opening in 2015, the institute will be be will institute the 2015, in Opening connections between disciplines. between connections Institute is complete, our team will be be will team our complete, is Institute understanding of health and disease. and health of understanding and distinctive medical research institute. institute. research medical distinctive and creative approaches, and explore explore and approaches, creative Until construction of the Francis Crick Crick Francis the of construction Until we expect to achieve quicker and more profound advances in our our in advances profound more and quicker achieve to expect we The Francis Crick Institute will be a new new a be will Institute Crick Francis The We take a long-term view, encourage encourage view, long-term a take We Trust and others. By pooling this collective knowledge and expertise, expertise, and knowledge collective this pooling By others. and Trust the three university founders and new recruits funded by the Wellcome Wellcome the by funded recruits new and founders university three the Imaginative Imaginative opportunities for the UK. the for opportunities these two organisations to work under one roof alongside colleagues from from colleagues alongside roof one under work to organisations two these generating economic economic generating National Institute of Medical Research (NIMR) − enabling scientists from from scientists enabling − (NIMR) Research Medical of Institute National afraid to do things differently. things do to afraid − Cancer Research UK’s London Research Institute (LRI) and the MRC MRC the and (LRI) Institute Research London UK’s Research Cancer − of human disease and and disease human of international stage, and are not not are and stage, international The Crick will bring together two existing world-class research institutes institutes research world-class existing two together bring will Crick The science, pursue excellence on the the on excellence pursue science, diagnosis and prevention prevention and diagnosis We support ground-breaking discovery discovery ground-breaking support We improving the treatment, treatment, the improving London); Imperial College London and King’s College London. London. College King’s and London College Imperial London); Bold Research Council (MRC); the Wellcome Trust; UCL (University College College (University UCL Trust; Wellcome the (MRC); Council Research underlying human health, health, human underlying respected scientifi c organisations: Cancer Research UK; the Medical Medical the UK; Research Cancer organisations: c scientifi respected To discover the biology biology the discover To We are: We The project is supported by six of the world’s most infl uential and and uential infl most world’s the of six by supported is project The for his discovery of the structure of DNA in 1953. in DNA of structure the of discovery his for awarded the Nobel Prize in Physiology or Medicine Medicine or Physiology in Prize Nobel the awarded VISION of British scientist Francis Crick, who was jointly jointly was
Recommended publications
  • M.S. and Ph.D. Sequences in Neuroscience and Physiology
    Neuroscience and Physiology are distinct but overlapping disciplines. • M.S. and Ph.D. students take three core Whereas Neuroscience investigates courses in neuroscience, physiology and neural substrates of behavior, Physiology biostatistics, and elective courses in more studies multiple functions. However, specific areas of these fields, as well as in M.S. and Ph.D. both seek to understand at an integrated related fields, such as cellular and level across molecules, cells, tissues, molecular biology, behavior, chemistry Sequences in whole organism, and environment. and psychology The workings of our brain and body • The curriculum provides a canonical Neuroscience and define us. When problems occur, results conceptual foundation for students can be devastating. According to the pursuing master’s and doctoral research in Physiology National Institutes of Health, neurological neuroscience and physiology and heart disease are two of the largest world health concerns and more than 50 • Our sequences provide a “cohort” million people in this country endure experience for new students, by offering a School of Biological some problem with the nervous system. cohesive curriculum for those students interested in pursuing graduate study in Sciences Our graduate sequences in Neuroscience neuroscience and physiology. and Physiology provide an exciting and Illinois State University challenging academic environment by combining research excellence with a strong commitment to education. We offer a comprehensive curriculum to graduate students interested in Neuroscience and Physiology. Both M.S. For more information, contact Dr. Paul A. and Ph.D. programs are also tightly Garris ([email protected]) or visit integrated into laboratory research. bio.illinoisstate.edu/graduate and goo.gl/9YTs4X Byron Heidenreich, Ph.D.
    [Show full text]
  • Biology Powerhouse Raises Railway Alarm
    NEWS IN FOCUS to enrol all participants by 2018. Certain factors make researchers optimis- tic that the British study will succeed where the US one failed. One is the National Health Service, which provides care for almost all pregnant women and their children in the United Kingdom, and so offers a centralized means of recruiting, tracing and collecting medical information on study participants. In the United States, by contrast, medical care is provided by a patchwork of differ- ent providers. “I think that most researchers in the US recognize that our way of doing population-based research here is simply different from the way things can be done in the UK and in Europe, and it will almost always be more expensive here,” says Mark Klebanoff, a paediatric epidemiologist at Nationwide Children’s Hospital in Colum- bus, Ohio, who was involved in early dis- cussions about the US study. The Francis Crick Institute sits at the nexus of three central London railway hubs. At one stage, US researchers had planned to knock on doors of random houses looking URBAN SCIENCE for women to enrol before they were even pregnant. “It became obvious that that wasn’t going to be a winning formula,” says Philip Pizzo, a paediatrician at Stanford University Biology powerhouse in Palo Alto, California, who co-chaired the working group that concluded that the National Children’s Study was not feasible. raises railway alarm “The very notion that someone was going to show up on your doorstep as a representa- tive from a govern­ment-funded study and Central London’s Francis Crick Institute fears that proposed say ‘Are you thinking of getting pregnant?’ train line will disrupt delicate science experiments.
    [Show full text]
  • Bloomsbury Scientists Ii Iii
    i Bloomsbury Scientists ii iii Bloomsbury Scientists Science and Art in the Wake of Darwin Michael Boulter iv First published in 2017 by UCL Press University College London Gower Street London WC1E 6BT Available to download free: www.ucl.ac.uk/ ucl- press Text © Michael Boulter, 2017 Images courtesy of Michael Boulter, 2017 A CIP catalogue record for this book is available from the British Library. This book is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International license (CC BY-NC-ND 4.0). This license allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Attribution should include the following information: Michael Boulter, Bloomsbury Scientists. London, UCL Press, 2017. https://doi.org/10.14324/111.9781787350045 Further details about Creative Commons licenses are available at http://creativecommons.org/licenses/ ISBN: 978- 1- 78735- 006- 9 (hbk) ISBN: 978- 1- 78735- 005- 2 (pbk) ISBN: 978- 1- 78735- 004- 5 (PDF) ISBN: 978- 1- 78735- 007- 6 (epub) ISBN: 978- 1- 78735- 008- 3 (mobi) ISBN: 978- 1- 78735- 009- 0 (html) DOI: https:// doi.org/ 10.14324/ 111.9781787350045 v In memory of W. G. Chaloner FRS, 1928– 2016, lecturer in palaeobotany at UCL, 1956– 72 vi vii Acknowledgements My old writing style was strongly controlled by the measured precision of my scientific discipline, evolutionary biology. It was a habit that I tried to break while working on this project, with its speculations and opinions, let alone dubious data. But my old practices of scientific rigour intentionally stopped personalities and feeling showing through.
    [Show full text]
  • Stem Strategy
    SUCCESS THROUGH STEM STEM STRATEGY In response to the ‘Report of the STEM Review’ HELPING TO EMPOWER FUTURE GENERATIONS THROUGH SCIENCE, TECHNOLOGY, ENGINEERING AND MATHEMATICS TO GROW A DYNAMIC, INNOVATIVE ECONOMY 2011 CONTENTS 1. INTRODUCTION 4 2. CONTEXT 5 3. THE ROLE OF THE DEMAND SIDE 8 4. THE ROLE OF THE SUPPLY SIDE 10 5. RECOMMENDATIONS FOR ACTION 15 6. STRUCTURES FOR IMPLEMENTATION 23 7. CONCLUSION AND PRIORITY ACTIONS 25 ANNEX A – Existing Government STEM Activity ANNEX B – Government STEM Action Plan 1. INTRODUCTION Commissioned by the Department for Employment The Report contains 20 recommendations grouped and Learning (DEL) and the Department of Education under four ‘imperatives’. (DE), the review of Science, Technology, Engineering • Imperative 1 - Business must take the lead and Mathematics (STEM) commenced formally on in promoting STEM. 29 June 2007. Chaired by Dr Hugh Cormican, founder and former Chief Executive of Andor Technologies • Imperative 2 - The key constraints in the STEM Ltd., the steering group comprised representatives artery must be alleviated. from business, government and academia and the Programme Manager for the review was Dr Alan Blair, • Imperative 3 - There needs to be increased from the Association of NI Colleges (now Colleges NI). flexibility in the provision of STEM education. Three working groups reported to the steering group, • Imperative 4 - Government must better each of which was responsible for taking forward a coordinate its support for STEM. key strand of the Review. These working groups ensured This STEM Strategy forms Government’s response a focus on the respective roles of business, education, to the ‘Report of the STEM Review’.
    [Show full text]
  • Jeremy Farrar
    FEATURE The BMJ THE BMJ INTERVIEW BMJ: first published as 10.1136/bmj.n459 on 19 February 2021. Downloaded from [email protected] Cite this as: BMJ 2021;372:n459 http://dx.doi.org/10.1136/bmj.n459 Jeremy Farrar: Make vaccine available to other countries as soon as Published: 19 February 2021 our most vulnerable people have received it The SAGE adviser and Wellcome Trust director tells Mun-Keat Looi how the UK government acted too slowly against the pandemic, about the perils of vaccine nationalism, and why he is bullish about controlling covid variants Mun-Keat Looi international features editor “Once the UK has vaccinated our most vulnerable among healthcare workers. We had no human communities and healthcare workers we should make immunity, no diagnostics, no treatment, and no vaccines available to other countries,” insists the vaccines. infectious disease expert Jeremy Farrar. This could Every country should have acted then. Singapore, avert further public health and economic disaster, China, and South Korea did. Yet most of Europe and he says, describing it as “enlightened self-interest, North America waited until the middle of March, and as well as the right ethical thing to do.” that defined the first wave. Countries including the In April 2020, soon after the first UK lockdown began, UK were unwilling to act early, before they felt Farrar predicted that the UK would have one of the comfortable; were unwilling to go deeper than they worst covid-19 death rates in Europe. As a member thought they had to; and were unwilling to keep of the Scientific Advisory Group for Emergencies restrictions in place for as long as was needed.
    [Show full text]
  • Programme Final (1).Pages
    BSHS Postgraduate Conference 2015 Programme !1 The British Society for the History of Science is a company limited by guarantee: registration number 562208 and charity number 258854. BSHS Executive Secretary PO Box 3401, Norwich NR7 7JF (+44) 01603516236 Email: offi[email protected] Webpage: www.bshs.org.uk © 2014, British Society for the History of Science !2 BSHS POSTGRADUATE CONFERENCE UCL Department of Science and Technology Studies 7 – 8 – 9 JANUARY 2015 The Department of Science and Technology Studies at University College London welcomes you to the BSHS Postgraduate Conference 2015! This event is an annual conference for postgraduate scholars in the history, philosophy and sociology of science, technology and medicine interested in meeting and sharing research with other postgraduate scholars. This is a great opportunity to build professional and social networks within a supportive and constructive environment. We had an outstanding response for paper submissions and postgraduate attendance, and we are looking forward to an extraordinary conference this year. Thank you for your contribution! Sincerely, BSHS Postgraduate Conference 2015 Committee Elizabeth Jones Raquel Velho Erman Sozudogru !3 " !4 Blue: Grey: Yellow: Grant Museum of Zoology UCL Roberts Building Holiday Inn Bloomsbury 21 University Street Torrington Place Coram Street London WC1E 6DE London WC1E 7JE London WC1N 1HT CONFERENCE INFORMATION Webpage: http://www.bshs.org.uk/conferences/postgraduate-conference/2015- postgraduate-conference-ucl Facebook: https://www.facebook.com/BSHS.PG.15
    [Show full text]
  • Uclpartners Academic Health Science Partnership
    UCLPartners academic health science partnership Professor the Lord Ajay Kakkar, Chair, UCLPartners Professor Sir David Fish, Managing Director, UCLPartners Dr Charlie Davie, Director of UCLPartners AHSN Clare Panniker, Chief Executive, Basildon and Thurrock University Hospitals NHS Foundation Trust What is UCLPartners? Six million population 23 healthcare organisations acute and 11 higher education institutes mental health trusts; community providers and research networks 20 Clinical Commissioning Groups (CCGs) Industry partnerships in research and 26 boroughs and local councils translation of innovation into health and wealth 2 Local Enterprise Partnership – key challenge • Working with the London Enterprise Panel, established by the Mayor of London • Professor Stephen Caddick, Vice Provost (Enterprise), UCL, is the only academic representative on the Panel • Key challenges of the panel: to compete with Boston and San Francisco; improve access to the NHS market to increase venture capital • How UCLPartners is contributing: working with industry to co-create technology and devices; creating long-term partnerships with industry and giving confidence to entrepreneurs, e.g. through new business models and procurement initiatives • Other areas of joint working: MedCity, Care City, London Health Commission, three London AHSNs and preparing to enable the success of the Francis Crick Institute 3 Defragmenting the pathway – an integrated journey to transform healthcare through innovation into practice Bringing together formal designations under
    [Show full text]
  • Evidence Synthesis on the EU-UK Relationship on Research and Innovation January 2018
    Evidence synthesis on the EU-UK relationship on research and innovation January 2018 1. Introduction The Royal Society and the Wellcome Trust have undertaken a rapid evidence synthesis on the EU-UK research and innovation relationship as part of their Future Partnership Project. Organisations and individuals were invited to submit evidence and analyses for inclusion. Evidence was also gathered through internet searches to ensure an inclusive approach. The Annex is a summary of the methods. Two questions were used in gathering evidence and in determining the material in scope: 1. What incentives, infrastructure and mechanisms can be accessed by research and innovation organisations, funders and individuals in Member States to support collaborations? 2. How do Member States currently use and benefit from these and how might they be affected by Brexit? This paper is a synthesis of the evidence and covers funding, infrastructures, mobility, collaboration and regulation, with a focus on links between the EU and the UK. 2. Overview of the evidence base A few major reports were of particular relevance; the Royal Society’s three reports on the role of the EU in UK research and innovation and two reports commissioned from Technopolis Group by UK organisations, on the role of EU funding in UK research and innovation and the impact of collaboration: the value of UK medical research to EU science and health1,2. These documents were often referenced in other submissions. A report from the Lords Science and Technology Committee’s inquiry on EU Membership and UK Science also summarises many sources of evidence relevant to this synthesis.
    [Show full text]
  • Biography (Modified, After Festetics 1983)
    Konrad Lorenz’s Biography (modified, after Festetics 1983) 1903: Konrad Zacharias Lorenz (KL) was born in Altenberg /Austria on Nov. 7 as the last of three children of Emma Lorenz and Dr. Adolf Lorenz, professor for orthopedics at the Medical branch of the University of Vienna. In the same year the representative and spacious Altenberg family home was finished. 1907: KL starts keeping animals, such as spotted newts in aquaria, raises some ducklings and is not pleased by his first experiences with a dachshound. Niko Tinbergen, his lifelong colleague and friend, is born on April 15 in Den Haag, The Netherlands. 1909: KL enters elementary school and engages in systematic studies in crustaceans. 1910: Oskar Heinroth, biologist and founder of "Vergleichende Verhaltensforschung" (comparative ethology) from Berlin and fatherlike scientific mentor of the young KL publishes his classical paper on the ethology of ducks. 1915: KL enters highschool (Schottengymnasium Wien), keeps and breeds songbirds. 1918: Wallace Craig publishes the comparative ethology of Columbidae (pigeons), a classics of late US biologist Charles O. Whitman, who was like O. Heinroth, a founding father of comparative ethology. 1921: KL excels in his final exams. Together with friend Bernhard Hellmann, he observes and experiments with aggression in a cichlid (Herichthys cyanoguttatum). This was the base for KL's psychohydraulic model of motivation. 1922: Father Adolf sends KL to New York to take 2 semesters of medicine courses at the ColumbiaUniversity, but mainly to interrupt the relationship of KL with longterm girlfriend Gretl Gebhart, his later wife. This paternal attempt to influence the mate choice of KL failed.
    [Show full text]
  • 2021 Phd Projects and Supervisory Teams Doctoral Fellowships for Clinicians
    2021 PhD projects and supervisory teams Doctoral Fellowships for Clinicians The role of “persistent PAMPs” in the cytokine storm and ARDS during severe COVID-19 and highly pathogenic influenza infection. Supervisory team: David Bauer (primary supervisor, Crick) and Mahdad Noursadeghi (UCL). Inflammation associated with SARS-CoV-2 infection. Supervisory team: Rupert Beale (primary supervisor, Crick) and Wendy Barclay (Imperial College London) Effect of acute myeloid leukaemia on normal haematopoiesis. Supervisory team: Dominique Bonnet (primary supervisor, Crick) and David Taussig (The Institute of Cancer Research, Royal Marsden) Investigation and modelling of multiple myeloma pathogenetic evolution. Supervisory team: Dinis Calado (primary supervisor, Crick), Richard Houlston (The Institute of Cancer Research) and Martin Kaiser (The Institute of Cancer Research, Royal Marsden) TGF-b family ligands as potential therapeutic targets in pancreatic cancer. Supervisory team: Caroline Hill (primary supervisor, Crick) and Debashis Sarker (King’s College London) Development of multisynaptic tracing technologies to target and manipulate disease- relevant neural circuits. Supervisory team: Johannes Kohl (primary supervisor, Crick), Andrew Murray (UCL) and Rickie Patani (Crick/UCL) Human Cell Atlas: single-cell transcriptomics of vitiligo. Supervisory team: Nicholas Luscombe (primary supervisor, Crick), Magnus Lynch (King’s College London) and John Ferguson (King’s College London) Structural and biochemical analysis of Salmonella effector functions and their interaction with host proteins. Supervisory team: Katrin Rittinger (primary supervisor, Crick), Teresa Thurston (Imperial College London) and Rupert Beale (Crick) Developing new viral vectors for in vivo gene therapy. Supervisory team: Sam Rodriques (primary supervisor, Crick), Matthew Walker (UCL) and Rob Brownstone (UCL) Identifying and functionally characterising non-coding drivers of renal cancer evolution.
    [Show full text]
  • Janet Thornton / 19 July 2018
    Oral History: Janet Thornton / 19 July 2018 DISCLAIMER The information contained in this transcript is a textual representation of the recoded interview which took place on 2018-07-19 as part of the Oral Histories programme of the EMBL Archive. It is an unedited, verbatim transcript of this recorded interview. This transcript is made available by the EMBL Archive for free reuse for research and personal purposes, providing they are suitably referenced. Please contact the EMBL Archive ([email protected]) for further information and if you are interested in using material for publication purposes. Some information contained herein may be work product of the interviewee and/or private conversation among participants. The views expressed herein are solely those of the interviewee in his private capacity and do not necessary reflect the views of the EMBL. EMBL reserves the right not to be responsible for the topicality, accuracy, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. 2 2018_07_19_JanetThornton Key MG: Mark Green, former head of Administration at EMBL-EBI JT: Participant, Janet Thornton, former Director of EMBL-EBI and current EMBL-EBI Research Group Leader [??? At XX:XX] = inaudible word or section at this time MG: My name is Mark Green. This is Thursday 19th July 2018 and I’m in the Pompeian Room in Hinxton Hall on the Wellcome Genome Campus where EMBL-EBI is based and I’m about to do an interview as part of the oral histories programme of the EMBL Archive, with Janet Thornton, and I’d just like to ask Janet to introduce herself and to say a bit about her life before EMBL.
    [Show full text]
  • Francis Crick Institute-CS-JB080719.Indd
    The Francis Crick Institute THE FRANCIS CRICK INSTITUTE The Crick is a landmark partnership between three of the UK’s largest funders of biomedical research: the Medical Research Council, Cancer Research UK and the Wellcome Trust, and three of its leading universities: UCL, Imperial College London and King’s College London. This represents an unprecedented joining of forces to tackle major scientific problems and generate solutions to the emerging health challenges of the 21st century. Business Challenge: The VIRTUS Solution: The Crick is being built in central London, where space is at a Collaboration is at the heart of the Crick’s vision. Its work premium. It was decided, early in the planning process, that will help to understand why disease develops and to find most of the Crick’s data would need to be stored off-site. new ways to diagnose, prevent and treat a range of illnesses However, the institute realised there were major benefits to – such as cancer, heart disease and stroke, infections and sharing resources with other institutions, particularly in terms neurodegenerative diseases. The Crick will bring together of scientific analysis. As the Crick’s plans developed, a number outstanding scientists from all disciplines, carrying out research of institutions – both within the original partners and more that will help improve the health and quality of people’s lives, broadly - had similar requirements and identified the same and keeping the UK at the forefront of medical innovation. potential for collaboration in having a colocated shared data centre. “The Crick has been proud to take a leading role in support of Janet.
    [Show full text]